On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayJun 15, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) and Interpublic Group (NYSE: IPG) Announce Partnership to Use Quantum Computing Applications for Innovation in Marketing Investments and Strategies

The partnership will leverage D-Wave’s Leap(TM) quantum cloud service coupled with IPG’s data assets IPG recently launched a pilot program with D-Wave to build marketing optimization equations for one of the company’s top 20 clients in the retail industry Leap provides access to the Advantage quantum computing system and quantum hybrid solvers, enabling users to tackle complex problems of up to 1 million variables and 100,000 constraints D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering customer value via practical quantum computing solutions, recently announced a partnership with one of the world’s leading…

Continue Reading

ThursdayJun 15, 2023 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) May Announcements Show Resolve to Continue Supporting R&D ‘Lifeblood’

In May, Lexaria made a number of positive announcements related to its R&D initiatives In addition to holding its 2023 Annual Meeting, the company completed dosing for its human clinical nicotine study, NIC-H22-1 Lexaria also reported 900% improvements in delivery of DehydraTECH(TM) processed estrogen into blood plasma in an animal study In a human hypertension study, the comfpany announced that its DehydraTECH-CBD formulation resulted in significant reductions in the blood plasma levels of pro-inflammatory biomarkers (IL 8, 10, and 18) These biomarkers are linked to cardiovascular disease (“CVD”) and many other conditions, such as asthma, lung diseases, chronic kidney disease,…

Continue Reading

WednesdayJun 14, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Announces Positive Data From Phase 1 Clinical Trial Evaluating REQORSA(R) Immunogene Therapy for Late-Stage Non-Small Cell Lung Cancer

The positive data from the Acclaim-1 Phase 1 portion of the Phase 1/2 clinical trial has been published in an abstract at the 2023 American Society of Clinical Oncology Annual Meeting, which took place in Chicago, IL and online June 2 – 6, 2023 Acclaim-1 is an open-label, multi-center Phase 1/2 clinical trial evaluating REQORSA(R) in combination with Tagrisso(R) The Phase 2 expansion portion of the study is expected to enroll approximately 66 patients – half of which will have only received Tagrisso(R) and the other half receiving Tagrisso(R) and chemotherapy The global lung cancer treatment market is expected to…

Continue Reading

WednesdayJun 14, 2023 9:00 am

Electronic Servitor Publication Network Inc. (XESP) Transforms B2B Companies with “Growth as a Service”

XESP’s proprietary Digital Engagement Engine(TM) develops real connections with target markets, pointing to the future of growth for B2B organizations The Digital Engagement Engine(TM) is a sophisticated technology stack that does 1-to-1 contact analysis and 1-to-1 content provisioning making sure that the right audience is reached and that interactions are productive XESP’s offering is called “Growth as a Service” which provides fully managed digital services focused on enhancing growth for B2Bs The digital landscape has transformed and evolved over the past few years – going from a focus primarily on SEO, to social media, content, and video marketing campaigns. Now,…

Continue Reading

TuesdayJun 13, 2023 9:45 am

2023 Reg A Conference Welcomes Investors, Companies Seeking Alternative Capital Raises

Companies looking for alternative methods of raising capital and investors interested in overlooked breakout opportunities will find the annual Reg A Conference, hosted by DealFlow Events, an exciting event to conduct business and learn about the current market. This year’s Reg A Conference will take place June 30 in New York’s luxurious Westchester Country Club, just a few minutes north of New York City. This one-day gathering provides insight on marketing strategies, a review of the current capital-raise landscape, news about regulatory oversight and analysis of what has (and hasn’t) worked in recent Reg A transactions. Our agenda for The…

Continue Reading

TuesdayJun 13, 2023 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Finalizes Department of Defense $4 Million Agreement for Demonstrating Critical REE Solution

Canada-based Ucore Rare Metals Inc. is devoted to establishing a North American-based supply chain for rare earth elements to reduce the Western hemisphere’s dependence on China’s market-dominant industries for modern technologies The company has developed a trademarked process for separating rare earths from their surrounding ores  Ucore is preparing to begin construction of a commercially scalable facility in Louisiana for using its solution The U.S. Department of Defense awarded the company $4 million in an agreement this month that calls on Ucore to demonstrate the capabilities of its technology and the company’s ability to use it for sustaining North American…

Continue Reading

MondayJun 12, 2023 12:00 pm

The SPAC Conference 2023: Access to Cutting-Edge Insights, Investments in Special Purpose Market

In the wake of the SPAC market correction brought on by liquidity flooding the capital and M&A markets during the past two years (https://ibn.fm/2dmFp), leading to proposed new U.S. Securities and Exchange Commission regulations (https://ibn.fm/aew7z), many investors have looked for opportunities to move beyond the sector’s financial limbo. DealFlow Events’ SPAC Conference 2023 is the ideal place to gather with industry thought leaders, experienced and respected professionals, and others who are engaged with special purpose acquisition companies. The 2023 lineup of speakers includes Donna Ackerly of Laurel Hill, James Graf of Graf Acquisition Corp, Jay Heller of Nasdaq, Eklavya Saraf…

Continue Reading

MondayJun 12, 2023 11:15 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Equipping Cashless Societies with Scalable Access to Payment Technologies and Solutions

Fintech Ecosystem Development seeks to offer a diverse portfolio of fintech-related products and services to consumers and businesses in Europe, South Asia, East Asia, Latin America, Africa, and the United States The company is looking to participate in the growing cashless payments space, where global payment transaction volumes are set to increase by almost 300% by 2030 FEXD intends to acquire or merge with pioneering fintech companies with, among others, a large customer base and the potential to be scaled up to global markets By executing its growth strategy, the company looks to equip cashless societies with scalable access to…

Continue Reading

MondayJun 12, 2023 10:30 am

Starco Brands, Inc. (STCB) Releases Skylar “Boardwalk Delight” Fragrance at Sephora, Sells Out Within Days

Fragrance allergies affect 2M+ people across the US, symptoms include skin redness, burning sensations, eyelid tearing, and swelling Skylar hypoallergenic fragrance line offers a safe alternative that doesn’t contain any of the 36 known allergens or 1,300+ “questionable” ingredients found in most fragrances Starco Brands recently released Skylar’s “Boardwalk Delight” scent at Sephora, sells out after 10 days All 10 Skylar scents are available at 500+ Sephora retail locations and online Fragrance allergies affect more than 2 million Americans, with symptoms that include skin redness, burning sensations, eyelid tearing, and swelling. Even simple sensitivities can trigger reactions like headaches, breathing…

Continue Reading

MondayJun 12, 2023 9:45 am

Recapping Data443 Risk Mitigation Inc.’s (ATDS) Transformative Acquisition and Breakthrough First Quarter Results

Data443 recently announced the acquisition of certain assets from Israeli-based cyber-security firm, Cyren Ltd., previously a company listed on the Nasdaq stock exchange The deal will see Data443 acquire capabilities within three significant revenue segments: threat intelligence, URL categorization, and email security The acquisition marks a major milestone, providing Data443 with direct access to customers with previously contracted revenues of approximately $15 million with upside potential The acquisition follows Data443’s First Quarter 2023 results, which saw dramatic increases in revenues (+125% YoY) and gross margins (over a third to 85%), driving a remarkable 184% YoY surge in gross profit Data443…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered